Graves Neuro-Immunology
Research Group
UC San Diego Multiple Sclerosis and Related Diseases Research Center
More About Our ResearchAreas of Research
- Biological Aging, Genetic and Environmental factors in MS — studying factors that drive disease severity in multiple sclerosis and related diseases
- Biosensing in Neurology — leveraging modern technology and biosensors to enhance neurological assessments and measurements of disease progression
- Visual System in Neuroimmunological Disease — identifying precise relationships between structural damage and functional outcomes
COVID-19 Research
NeuCOVID Study
Our research group has partnered with a range of neurology specialists in order to investigate the longitudinal neurological impacts of COVID-19. Our NeuCOVID study aims to track neurological symptom and disease developments and changes over a 10-year period through neuropsychological metrics and detailed interviews.
We are currently accepting new participants. If you have been diangosed with COVID-19 and have experienced neurological symptoms (headaches, brain fog, anosmia, etc.) and would like to participate in our study, contact Jacqui Shanley at jshanley@health.ucsd.edu.
Programs
Clinical Trial Program
With a commitment to bring new therapies to our patients, we run a clinical trials program for MS and related diseases. Contact us directly for up-to-date information on enrolling studies.
Pediatric Research Program
Our Neuroimmunology Research Group has partnered with Rady Children's Hospital, where Dr. Jennifer Graves runs a pediatric MS neurology clinic, to investigate MS and related diseases in children.
The Team
CONTACT US
For interest in research participation, contact Annalise Miner or visit our Contact page.
For training opportunities and collaborations, contact Jennifer Graves, M.D., Ph.D., MAS.
Our collaborators
- Dr. Tzzy-Ping Jung and Dr. Masaki Nakanishi at the Swartz Center for Computational Neuroscience
- Collaboration on the MSight Study and Mutli-Sensors
- Clinical applications of EEG/BCli (for information on how to participate in this study as a patient or a healthy control, please contact Annalise Miner)
